At the end of a year marked by wave after wave of layoffs in biopharma as the pandemic-era boom ended, respondents to two newly released BioSpace surveys indicate continued apprehension about the economy, and often their company’s future performance specifically. But there were bright spots; for example, a large majority of employees were happy with major aspects of their workplace environments.